Nature's "Fat Grabber"
Chitosan is a weight-loss aid from the sea. Chitosan, a fibrous material derived from the outer shell(exoskeleton) of crustaceans, absorbs dietary fat and carries it through the G.I. tract without being digested. Chitosan also helps lower cholesterol levels. Unlike dangerous and ineffective diet drugs which have marginal weight-loss benefits, chitosan
has proven more effective for weight loss. It also has been shown to lower blood pressure in weight loss studies.
Chitosan is also effective in kidney disease and kidney failure, helping prevent further deterioration of function.
Dosage: For weight loss, take 6 capsules at the beginning of a high-fat meal. Be sure to drink 8 ounces of water with each dose. For kidney failure, 3-6 caps, 3 times per day between meals or as directed by a physician.
Dr. Myatt's Comment: Use with high-fat meals. Great support formula for weight loss plans. Because your body needs certain fats (Essential Fatty Acids), and fat-soluble vitamins, chitosan is not recommended for use at every meal, only high-fat meals.
Each capsule contains:
Serving Size: 4 capsules
Servings Per Container: 45
Amount Per Serving:
- LipoSan ULTRA™ (high density chitosan marine fiber concentrate) 1000 mg
- Citric Acid 300 mg
- Lipase (3000 lipase units) 100 mg
Other Ingredients: gelatin, vegetable stearate
Contains ocean shrimp, soybean, wheat
Suggested Use: As a dietary supplement, take 4 capsules with 8 ounces of water, three times daily, before or immediately after meals, or as directed by a doctor.
Embarrassing Diet Drug Gets FDA OTC Approval
1.) FDA News, February 7, 2007.http://www.fda.gov/bbs/topics/NEWS/2007/NEW01557.html
2.) Comparison of orlistat and sibutramine in an obesity management program: efficacy, compliance, and weight regain after noncompliance. Eat Weight Disord. 2006 Dec;11(4):e127-32.
3.) Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients. Diabetes Obes Metab. 2005 Jan;7(1):47-55.
4.) Baseline serum folate level may be a predictive factor of weight loss in a morbid-obesity-management programme. Br J Nutr. 2006 Nov;96(5):956-64.
5.) Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet. 2007 Jan 6;369(9555):71-7. Summary: There are no studies to show if these drugs are safe for long-term use.
6.) Effect of chitosan on renal function in patients with chronic renal failure. J Pharm Pharmacol. 1997 Jul;49(7):721-3.
7.) Effect of chitosan in complex management of obesity. Pol Merkur Lekarski. 2002 Aug;13(74):129-32.